AI entity

Scott Weidley

Person

product-launch is the sole category represented across all 1 tracked stories. AI-Powered Clinical Trial Build Platform is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.9 across the same-window beat baseline.

Last mentioned: Mar 12, 2026

Entity pulse

Recent coverage · Scott Weidley

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Scott Weidley

product-launch is the sole category represented across all 1 tracked stories. AI-Powered Clinical Trial Build Platform is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.9 across the same-window beat baseline. Their average consequence score of 7 runs above the beat's 6.5 for that window. Scott Weidley appears in 1 tracked AI story from March 12, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 59 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Scott Weidley. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Implementation Phase

    Early adoption by sponsors and CROs to automate protocol-to-EDC translation.

  2. Platform Launch

    ClinCapture CEO Scott Weidley introduces the AI-powered study build engine.

Stories mentioning Scott Weidley 1

Product Launches Positive

ClinCapture Launches AI-Powered Architecture to Automate Clinical Trial Builds

ClinCapture CEO Scott Weidley has announced the integration of AI directly into the Captivate platform's architecture to automate the clinical trial build process. By converting static protocol documents into computable digital models, the new engine aims to significantly reduce manual configuration time and operational risk in life sciences research.

2 sources

Scott Weidley is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.